Skip to content

Bad science in health economics: complementary medicine, costs and mortality

By Chris Sampson, David Whitehurst and Andrew Street In December 2012, an article was published in The European Journal of Health Economics with the title ‘Patients whose GP knows complementary medicine tend to have lower costs and live longer’. We… Read More »Bad science in health economics: complementary medicine, costs and mortality

The potential of the super QALY to reconcile the key contentions in health economics

Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying this for a.very.long.time. Despite this, as… Read More »The potential of the super QALY to reconcile the key contentions in health economics